Aimei Health Technology Co., Ltd

Status: Pre-Deal
U=S+R R=S/5
IPO Proceeds, $M $69.00M
IPO Date Dec 4, 2023
CEO Mr. Junheng Xie
Left Lead Spartan Capital
IPO Cash in Trust 101.0%
SPAC Tenor 12 + (12*1)
IPO Sector Healthcare

Small cap companies domiciled in North America, Europe and/or the Asia Pacific regions that are developing assets in the biopharmaceutical, medical technology/medical device and diagnostics space

IPO Geography Global
Target Company TBD
Deal Announced TBD
Deal Size, $M TBD
Deal Sector TBD
Deal Geography TBD
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote TBD
AFJK AFJKU AFJKR

Sign up for Free Trial

No credit card required

Sign in for more on Aimei Health Technology Co., Ltd:

  • Structure and cap table
  • 5 directors & officers
  • 9 filings and events
  • 2 underwriters
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Mr. Junheng Xie 35 Chief Executive Officer, Secretary and Director
Heung Ming Wong 54 Chief Financial Officer and Director
Lin Bao 49 Director
Dr. Julianne Huh 54 Director
Robin Karlsen 30 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Spartan Capital BR 5,950,000 units
B. Riley FBR 50,000
6,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 2.00 %

Sign in to view more advisor data.

Filings

Sign in to view 9 filings.

Shareholders

Sign in to view shareholders 13F filing data.